{"id":4497,"date":"2026-04-15T16:00:31","date_gmt":"2026-04-15T20:00:31","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/"},"modified":"2026-09-24T00:05:30","modified_gmt":"2026-09-24T04:05:30","slug":"gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/","title":{"rendered":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025"},"content":{"rendered":"\n<strong>Paris, France, le 15 avril 2026<\/strong>, <strong>18<\/strong><strong>h00 CEST<\/strong> \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 14 avril 2026 son document d\u2019enregistrement universel (URD) 2025 en langue anglaise aupr\u00e8s de l\u2019Autorit\u00e9 des March\u00e9s Financiers (AMF) sous le num\u00e9ro D.26-0251.\n\nLe document d\u2019enregistrement universel inclut notamment :\n<ul>\n \t<li>le rapport financier annuel 2025 ;<\/li>\n \t<li>le rapport de gestion\u00a0;<\/li>\n \t<li>le rapport sur le gouvernement d\u2019entreprise ; et<\/li>\n \t<li>le descriptif du programme de rachat d\u2019actions.<\/li>\n<\/ul>\nCe document d\u2019enregistrement universel peut \u00eatre consult\u00e9 sur le site Internet de la Soci\u00e9t\u00e9 (www.gensight-biologics.com), section Investisseurs, et sur le site de l\u2019AMF (www.amf-france.org).\n","protected":false},"excerpt":{"rendered":"<p>Paris, France, le 15 avril 2026, 18h00 CEST \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 14 avril 2026 son document d\u2019enregistrement universel [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[],"news-type":[76,80],"post-year":[],"class_list":["post-4497","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-type-corporate","news-type-finance"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Paris, France, le 15 avril 2026, 18h00 CEST \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 14 avril 2026 son document d\u2019enregistrement universel [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-15T20:00:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:30+00:00\" \/>\n<meta name=\"author\" content=\"Arthus Moulin-Fournier\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arthus Moulin-Fournier\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/\"},\"author\":{\"name\":\"Arthus Moulin-Fournier\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/ae14918d0ec7c587d729420ef3ca5c18\"},\"headline\":\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025\",\"datePublished\":\"2026-04-15T20:00:31+00:00\",\"dateModified\":\"2026-09-24T04:05:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/\"},\"wordCount\":151,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/\",\"name\":\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2026-04-15T20:00:31+00:00\",\"dateModified\":\"2026-09-24T04:05:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/ae14918d0ec7c587d729420ef3ca5c18\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2026\\\/04\\\/15\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/ae14918d0ec7c587d729420ef3ca5c18\",\"name\":\"Arthus Moulin-Fournier\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eace44d269d162de11a066bf28b6d0de50aec912351357046a1db52e59b9cbf9?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eace44d269d162de11a066bf28b6d0de50aec912351357046a1db52e59b9cbf9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/eace44d269d162de11a066bf28b6d0de50aec912351357046a1db52e59b9cbf9?s=96&d=mm&r=g\",\"caption\":\"Arthus Moulin-Fournier\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/","og_locale":"fr_FR","og_type":"article","og_title":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025 - GenSight Biologics","og_description":"Paris, France, le 15 avril 2026, 18h00 CEST \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 14 avril 2026 son document d\u2019enregistrement universel [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/","og_site_name":"GenSight Biologics","article_published_time":"2026-04-15T20:00:31+00:00","article_modified_time":"2026-09-24T04:05:30+00:00","author":"Arthus Moulin-Fournier","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Arthus Moulin-Fournier","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/"},"author":{"name":"Arthus Moulin-Fournier","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/ae14918d0ec7c587d729420ef3ca5c18"},"headline":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025","datePublished":"2026-04-15T20:00:31+00:00","dateModified":"2026-09-24T04:05:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/"},"wordCount":151,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/","name":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2026-04-15T20:00:31+00:00","dateModified":"2026-09-24T04:05:30+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/ae14918d0ec7c587d729420ef3ca5c18"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2026\/04\/15\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/ae14918d0ec7c587d729420ef3ca5c18","name":"Arthus Moulin-Fournier","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/eace44d269d162de11a066bf28b6d0de50aec912351357046a1db52e59b9cbf9?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/eace44d269d162de11a066bf28b6d0de50aec912351357046a1db52e59b9cbf9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/eace44d269d162de11a066bf28b6d0de50aec912351357046a1db52e59b9cbf9?s=96&d=mm&r=g","caption":"Arthus Moulin-Fournier"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4497","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4497"}],"version-history":[{"count":2,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4497\/revisions"}],"predecessor-version":[{"id":7103,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4497\/revisions\/7103"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4497"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4497"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4497"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4497"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4497"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4497"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4497"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}